Literature DB >> 17579114

Effects of thiazolidinediones on differentiation, proliferation, and apoptosis.

Fu-Sheng Chou1, Pei-Shan Wang, Samuel Kulp, Joseph J Pinzone.   

Abstract

Thiazolidinediones induce adipocyte differentiation and thereby limit proliferative potential; hence, early investigations focused on their ability to modulate cellular proliferation and apoptosis. Several lines of evidence indicate significant thiazolidinedione-mediated antitumor activity. An emerging view is that some antitumor effects are totally or partially peroxisome proliferator-activated receptor-gamma (PPARgamma) dependent, whereas others are PPARgamma independent. The aim of this review is to examine the current evidence about the molecular mechanisms by which thiazolidinediones augment cellular differentiation, inhibit cellular proliferation, and induce apoptosis. We first address the role of thiazolidinediones and/or PPARgamma on Wnt/beta-catenin signaling pathway as it affects cellular differentiation and then discuss other pathways that are also involved in differentiation as well as proliferation and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17579114     DOI: 10.1158/1541-7786.MCR-06-0278

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  23 in total

1.  Impact of elastin-derived VGVAPG peptide on bidirectional interaction between peroxisome proliferator-activated receptor gamma (Pparγ) and beta-galactosidase (β-Gal) expression in mouse cortical astrocytes in vitro.

Authors:  Konrad A Szychowski; Jan Gmiński
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-12-03       Impact factor: 3.000

Review 2.  Early drug development of inhibitors of the insulin-like growth factor-I receptor pathway: lessons from the first clinical trials.

Authors:  Jordi Rodon; Victoria DeSantos; Robert Jean Ferry; Razelle Kurzrock
Journal:  Mol Cancer Ther       Date:  2008-09       Impact factor: 6.261

3.  Ciglitazone, a novel inhibitor of lung apoptosis following hemorrhagic shock.

Authors:  Ranjit S Chima; Paul W Hake; Giovanna Piraino; Prajakta Mangeshkar; Michael O'Connor; Basilia Zingarelli
Journal:  Int J Clin Exp Med       Date:  2010-01-01

4.  Peroxisome proliferator-activated receptor (PPAR)gamma can inhibit chronic renal allograft damage.

Authors:  Eva Kiss; Zoran V Popovic; Jens Bedke; Judith Adams; Mahnaz Bonrouhi; Andrea Babelova; Claudia Schmidt; Frank Edenhofer; Inka Zschiedrich; Sophie Domhan; Amir Abdollahi; Liliana Schäfer; Norbert Gretz; Stefan Porubsky; Hermann-Josef Gröne
Journal:  Am J Pathol       Date:  2010-04-02       Impact factor: 4.307

Review 5.  Anti-Diabetic Drugs: Cure or Risk Factors for Cancer?

Authors:  Jeny Laskar; Kasturi Bhattacharjee; Mahuya Sengupta; Yashmin Choudhury
Journal:  Pathol Oncol Res       Date:  2018-03-13       Impact factor: 3.201

6.  Cytotoxic effects of statins and thiazolidinediones on meningioma cells.

Authors:  Sonja Gehring; Jorge Humberto Tapia-Pérez; Elmar Kirches; Raimund Firsching; Gerburg Keilhoff; Thomas Schneider; Christian Mawrin
Journal:  J Neurooncol       Date:  2010-08-30       Impact factor: 4.130

7.  Antitumor activity of a novel series of alpha-aryloxy-alpha-methylhydrocinnamic acid derivatives as PPAR gamma agonists against a panel of human cancer cell lines.

Authors:  Xishan Xiong; Yangliang Ye; Lili Fu; Bing Dai; Jieqiong Liu; Jieshuang Jia; Jing Tang; Lin Li; Li Wang; Jianhua Shen; Changlin Mei
Journal:  Invest New Drugs       Date:  2008-08-13       Impact factor: 3.850

8.  Pyrimidinyl-arylpropionic acid derivatives: viable resources in the development of new antineoplastic agents.

Authors:  Xishan Xiong; Li Wang; Yangliang Ye; Lili Fu; Minli Chen; Qingyi Wang; Moyan Liu; Jing Tang; Bing Dai; Jianhua Shen; Changlin Mei
Journal:  Invest New Drugs       Date:  2009-06-17       Impact factor: 3.850

9.  DH9, a novel PPARγ agonist suppresses the proliferation of ADPKD epithelial cells: An association with an inhibition of β-catenin signaling.

Authors:  Moyan Liu; Lili Fu; Chunyan Liu; Xishan Xiong; Xiang Gao; Min Xiao; Houan Cai; Huimin Hu; Xueqi Wang; Changlin Mei
Journal:  Invest New Drugs       Date:  2009-09-16       Impact factor: 3.850

10.  New target genes for the peroxisome proliferator-activated receptor-γ (PPARγ) antitumour activity: Perspectives from the insulin receptor.

Authors:  Daniela P Foti; Francesco Paonessa; Eusebio Chiefari; Antonio Brunetti
Journal:  PPAR Res       Date:  2009-06-29       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.